Choose a Global Block from the dropdown.
Delta Life Science Introduces Faster, More Flexible Approach to Multiplexed Biomolecular Analysis
August 13, 2026
·
Funding
Delta Life Science today announced the latest capabilities of its inQuiQ™ nanophotonic sensing platform, giving researchers a flexible way to perform multiplexed biomolecular analysis while reducing assay complexity and sample requirements.
ROTTERDAM — August 2026 — Delta Life Science today announced the latest capabilities of its inQuiQ™ nanophotonic sensing platform, giving researchers a flexible way to perform multiplexed biomolecular analysis while reducing assay complexity and sample requirements.
The inQuiQ platform uses nanophotonic evanescent field sensing to monitor molecular interactions directly at the sensor surface. With multiple independent flow channels and support for multiplexed chip formats, researchers can analyse different targets, controls and assay configurations from the same sample injection.
“Researchers shouldn’t have to redesign an assay every time they move from one target to a broader panel”
Sjonnie Doe, Delta Life Science
The platform is designed for applications ranging from binding and kinetic analysis to biomarker research, antibody characterisation and other protein interaction studies. Its workflow can accommodate both in-flow immobilisation and higher-density spotted surfaces, allowing users to select the format that best fits their experimental requirements.
The inQuiQ 768 further extends the platform for higher-throughput workflows, supporting analysis from 96- and 384-well plate formats and enabling laboratories to move from individual experiments toward larger screening and profiling campaigns.
“Multiplexing isn’t useful simply because it produces more data,” added [Name]. “The real value is being able to answer more of the biological question from the same experiment.”
Delta Life Science will continue expanding the inQuiQ platform and its application portfolio throughout 2026, supporting researchers across academia, biotechnology and pharmaceutical development.
About Delta Life Science
Delta Life Science develops analytical technologies based on nanophotonic sensing. Its inQuiQ™ platform enables real-time analysis of biomolecular interactions with a focus on flexibility, multiplexing and accessible workflows for modern life science research.